Viac ako 4 milióny titulov v angličtine aj ďalších jazykoch! Objavte svoj nový príbeh ešte dnes!

Anticancer Drug Development Guide

Name: Anticancer Drug Development Guide
Brand: Humana Press Inc.
SKU: 9781468498417
Price: 146.31 EUR
Availability: InStock

Preclinical Screening, Clinical Trials, and Approval

Autor: Beverly A. Teicher, Paul A. Andrews

Jazyk:

Väzba: Brožovaná

Vydavateľ: Humana Press Inc.

Dostupnosť: Skladom u dodávateľa

Odosielame za 5-8 dní

146.31 €

This unique volume traces the critically important pathway by which a "molecule" becomes an "antican...

Informácie o knihe

Autor

Beverly A. Teicher, Paul A. Andrews

Jazyk

Angličtina

Väzba

Kniha - Brožovaná

Vydalo

2012

Stránok

451

EAN

9781468498417

ISBN

146849841X

Enbook ID

05258311

Vydavateľ

Humana Press Inc.

Hmotnosť

883

Rozmery

178 x 254 x 26

Kompletný popis

This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors.

Najčastejšie vyhľadávané

Categories

Authors

Publishers

Produkty

Produkty

Najčastejšie vyhľadávané

Categories

Authors

Publishers

Produkty

Produkty

Anticancer Drug Development Guide

Preclinical Screening, Clinical Trials, and Approval

Informácie o knihe

Kompletný popis

Mohlo by vás zaujímať

Zákazníci, ktorí si kúpili túto knihu, kúpili tiež